EVEREST ORGANICS LTD. SHARE PRICE [LIVE]

BSE: INE334C01029   NSE: EVERESTO   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
135.00
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in EVEREST ORGANICS LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

EVERESTO News

Frequently Asked Questions

What is the Share price of EVEREST ORGANICS LTD. (EVERESTO)?

EVEREST ORGANICS LTD. (EVERESTO) share price as of August 16, 2022, on BSE is Rs 135.00 (BSE).

Can I buy EVEREST ORGANICS LTD. (EVERESTO) shares?

Yes, You can buy EVEREST ORGANICS LTD. (EVERESTO) shares by opening a Demat account with Angel One.

How do I buy EVEREST ORGANICS LTD. (EVERESTO) from Angel One?

EVEREST ORGANICS LTD. (EVERESTO) share can be brought through the following modes:
  1. Direct investment: You can buy EVEREST ORGANICS LTD. (EVERESTO) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to EVEREST ORGANICS LTD. (EVERESTO) shares.

In which sector do EVEREST ORGANICS LTD. (EVERESTO) belong?

EVEREST ORGANICS LTD. (EVERESTO) belongs to Pharma.

About EVERESTO

Today's live share price for EVEREST ORGANICS LTD. is NSE: N/A, BSE: ₹ 135.00 with a current market capitalization of .

Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The company set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen. The company has increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa.The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA.

Read more